TRV TRAVELERS COMPANIES, INC. Insider Trading

EVP Klein sells 10,000 shares at avg $307.65 for $3.1M; retains 45.1K shares post-sale

Michael Frederick Klein, EVP & President of Personal Insurance, executed three separate sales totaling 10,000 shares for $3,076,545.97 on 2026-05-26, with transaction prices ranging from $307.10 to $308.79. Post-transaction, Klein retains 45,124 shares, representing an 18.1% reduction from his pre-transaction holdings of 55,124 shares. His cross-ticker track record shows 19 prior open-market sales; however, outcomes for his 5 prior TRV trades remain unmeasurable. The company's latest quarterly fundamentals show revenue of $11,924,000,000.00 and net income of $1,711,000,000.00, with annual revenue growth at +5.2%. The sale size and pattern are consistent with an executive executing a planned reduction of a significant but not dominant portion of his holdings.

EVP Andy F Bessette sells 4,255 TRV shares at $308.11; retains 24,284 shares post-transaction.

Andy F Bessette, EVP and Chief Admin Officer of Travelers Companies, sold 4,255 shares at $308.11 on 2026-05-22, retaining 24,284 shares (24.3K shares) afterward. This represents a -14.9% reduction from his pre-transaction holdings of 28,539 shares (28.5K shares). His prior sells at TRV show mixed timing outcomes: 1 of 5 prior sales were well-timed at the 90-day mark, with most recent TRV sales in February 2026 posting near-flat 30-day returns (-0.1% to -0.7%) followed by modest 90-day gains (2.3% to 2.9%), while his cross-ticker track record across 8 prior open-market sales averaged a 90-day return of +3.5% with a well-timed rate of 28.57% — indicating his sells have historically occurred before stock appreciation rather than declines. The company reported revenue of $11.9B (latest quarter), net income of $1.7B, and annual revenue growth of +5.2%, providing a stable fundamental backdrop against which to assess this partial reduction in holdings.

Vice Chmn. & Chief Legal Officer sells 6,735 shares (6.7K) of TRV at $308.78 for $2,079,640.04; stock near 52-week highs.

Kess Avrohom J. sold 6,735 shares at $308.78 on 2026-04-28, reducing holdings by -12.1% vs pre-transaction levels. The sale occurred near the stock's 52-week high of $312.03 (-3.1% from peak), and the current price of $302.25 sits 30-day +3.6% and 90-day +6.3% above the transaction date. At the same ticker (TRV), his prior 3 measurable sells all posted negative 90-day returns (-1.3%, -4.2%, -4.0%, -3.6%), establishing a 100% well-timed rate over his TRV-specific history. His cross-ticker track record shows 4 prior sells with a 100% well-timed rate overall, though with modest average 90-day decline of -0.6%. TRAVELERS carries fundamental strength with $11.9B revenue, $1.7B net income, 5.2% annual revenue growth, and a P/E of 8.45, suggesting stable underlying business. The sale's placement near 52-week highs combined with his consistent pattern of selling before subsequent declines warrants tracking of whether this transaction signals another well-timed exit or represents a departure from his established pattern.

EVP Jeffrey Klenk sells 6,413 TRV shares at $305.06; holdings reduced 51.4% to 6,075 shares post-transaction.

Klenk executed a substantial single transaction selling 6,413 shares at $305.06 on 2026-04-20, reducing his TRV holdings by 51.4% from 12,488 to 6,075 shares. Against current price of $301.42, the transaction price represents a modest premium; relative to the 52-week high of $312.03, the sale occurred near peak valuation (only -3.4% below range ceiling). His prior three measurable same-ticker sales at TRV show mixed timing results (2 of 3 well-timed at the 90-day mark, but one at 2025-05-29 declined further, and the most recent 2026-01-23 sale showed strong 30-day performance with 90d outcome not yet measurable). At a company-wide level, TRV's fundamentals remain solid with $11.9B revenue, $1.7B net income, +5.2% annual growth, and a low P/E of 8.43. The magnitude of this reduction—roughly half his accumulated position—marks a material portfolio adjustment by a senior executive, though the pattern of his same-ticker activity lacks strong predictive consistency to signal broader forward outlook.

Klein sells 10,000 TRV shares ($3.0M) at $303.77 avg; stock now $301.42; prior TRV trades poorly timed at 90d.

Michael Frederick Klein, EVP & President of Personal Insurance, executed 2 separate sales on 2026-04-20 totaling 10,000 shares for $3,037,690.74, reducing his holdings from 55,124 shares to 45,124 shares (-18.1%). The blended average price of $303.77 was near the 52-week high of $312.03. Klein's prior 4 measurable sales at TRV show a 90-day timing pattern of just 1 well-timed sale, with the most recent February 2026 sale up +1.7% at 30 days but outcome not yet measurable at 90 days. His cross-ticker track record across 19 prior sells shows a 66.67% well-timed rate and an average 90-day return of -1.1%, but at TRV specifically, timing has been inconsistent: 3 of 4 prior sales resulted in positive 90-day returns, meaning the stock rose after he sold.

EVP Olivo sells 10,400 TRV shares at $306.60; remains 124,742 shares long post-transaction.

Olivo, EVP and Chief Risk Officer, sold 10,400 shares on 2026-02-26 at $306.60, reducing holdings by 7.7% to 124,742 shares. The transaction occurred near the 52-week high of $308.64, though within days of a prior discretionary sale on 2026-02-06. Across his five measurable prior trades at TRV, his timing has been mixed: 2 of 4 prior sales showed negative 90-day returns (well-timed to subsequent declines), but the other 2 were positive, and the most recent sale on 2025-11-26 showed only +3.3% 90-day return. His cross-ticker track record shows 7 prior sales with a 50% well-timed rate and a 5.6% average 90-day return, meaning his sells have typically preceded modest gains rather than declines. The company fundamentals are solid with $12.5B revenue, $1.9B net income, 5.2% annual revenue growth, and a low P/E of 9.32, providing no obvious distress signal.

EVP Donnay sold 4,731 shares of TRV at $308.52; stock near 52-week highs, holdings reduced 31.1%.

Rowland David Donnay sold 4,731 shares at $308.52 on 2026-02-26, reducing his holdings by 31.1% and representing $1,459,603.86 in proceeds. The transaction occurred with TRV trading near its 52-week high of $308.64, having appreciated 9.4% over the prior 30 days and 5.4% over 90 days. At the same-ticker level, Donnay's prior 5 trades at TRV show mixed 90-day outcomes: 3 of 5 sales resulted in stock declines afterward (well-timed), while 2 were followed by gains. The current sale's placement near the 52-week peak is noteworthy against a company with strong fundamentals—$12.5B quarterly revenue, $1.9B net income, and a P/E of 9.32—but without explicit rationale disclosed, the sale's motivations remain opaque.

SVP Paul Munson sold 3,727 shares (83.5% of holdings) at $306.04, near 52-week high

Paul E. Munson, SVP & Corp. Controller at Travelers Companies, Inc., executed two separate sales on 2026-02-25, selling 927 shares and 2,800 shares totaling 3,727 shares for $1,140,611.08 at $306.04 per share. This represents an 83.5% reduction in his shareholdings, reducing his post-transaction position to 735 shares. The sale occurred at the 52-week high of $306.24, with the stock up 8.9% over the prior 30 days and 4.6% over 90 days. Munson's prior cross-ticker sell history shows a 100% well-timed rate with a 90-day return of -0.4%, and his previous TRV sale on 2025-05-29 also exhibited negative 90-day returns, establishing a consistent pattern. The company's fundamentals remain solid—$12.5B in quarterly revenue, $1.9B in net income, and a P/E of 9.24—but the magnitude of this reduction in an executive's personal stake near peak valuation merits investor attention to company guidance and forward-looking signals.

Vice Chairman Heyman sells 5,000 TRV shares in 4 transactions totaling $1.5M at $306.75 avg, retaining 259,590 shares

William H. Heyman, Vice Chairman of Travelers, executed 4 separate sales totaling 5,000 shares for $1,533,755.10 on February 20 and 23, 2026, reducing his position from 264,590 to 259,590 shares (-1.9%). The sales occurred near the current price of $305.43 and within 0.0% of the 52-week high, as the stock has appreciated +10.0% over the prior 30 days. Across Heyman's cross-ticker sell history, his prior 20 sales averaged a 90-day return of +2.2%, indicating his past sales have generally preceded further price appreciation; by contrast, his prior 3 measurable sales at TRV all showed positive 90-day returns, meaning none were well-timed at the 90-day mark. The sales represent a modest portfolio reduction of less than 2% of Heyman's TRV holdings and occur in the context of a company with strong fundamentals (P/E 9.22, $1.9B net income, $12.5B quarterly revenue).

EVP Gregory Toczydlowski sells 12,199 TRV shares at $299.76; holds 18,416 post-transaction, down 39.8% from 30,615.

Toczydlowski sold 12,199 shares for $3,656,983.95 on 2026-02-20, reducing his holdings by 39.8%, a substantial single-transaction reduction for a senior executive. The sale occurred at $299.76, just shy of the 52-week high of $305.39, suggesting execution near recent strength. However, his prior three trades at Travelers show mixed timing results: his 2025-07-21 sale was followed by a +3.1% 30-day gain but -1.6% over 90 days, while his 2024 trades had modestly positive or neutral longer-term outcomes, with only 1 of 3 prior sells well-timed at the 90-day mark. Against this uneven track record at the ticker and given the company's solid fundamentals—$12.5B quarterly revenue, $1.9B net income, 5.2% annual revenue growth, and a P/E of 9.22—the sale alone does not suggest executive concern, but the magnitude of the reduction warrants observation of whether this pattern continues or represents a portfolio adjustment.